Table 1.
Antibody | Clone | Vendor | Working dilution |
---|---|---|---|
ER | SP1 | Ventana | RTU |
PR | 1E2 | Ventana | RTU |
HER2 | 4B5 | Ventana | RTU |
EMA | E29 | Ventana | RTU |
CK7 | OV-TL 12/30 | Dako | 1:1600 |
S100 | pAb (Rabbit) | Dako | 1:8000 |
Collagen IV | CIV22 | Ventana | RTU |
Laminin | pAb (Rabbit) | Biogenex | 1:100 |
α-1-Antitrypsin | pAb (Rabbit) | Ventana | RTU |
α-1-Antichymotrypsin | pAb (Rabbit) | Ventana | RTU |
GCDFP-15 | D6 | Covance | 1:1000 |
Synaptophysin | SNP88 | Biogenex | 1:2000 |
Chromogranin | LK2H10 | Ventana | RTU |
Mammaglobin | 31A5 | Ventana | RTU |
Lysozyme | pAb (Rabbit) | Ventana | RTU |
Amylase | pAb (Rabbit) | Nordic Immunology | 1:5000 |
Abbreviations: ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2; EMA, epithelial membrane antigen; GCDFP-15, gross cystic disease fluid protein 15; RTU, ready to use.